IPSC icon

Century Therapeutics

0.5025 USD
-0.0289
5.44%
At close Updated Dec 3, 12:24 PM EST
1 day
-5.44%
5 days
-5.19%
1 month
-16.25%
3 months
7.33%
6 months
-11.86%
Year to date
-51.68%
1 year
-67.58%
5 years
-97.8%
10 years
-97.8%
 

About: Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Employees: 165

0
Funds holding %
of 7,494 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 3 articles
Price charts implemented using Lightweight Charts™